Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sastasundar Ventures Limited ( (IN:SASTASUNDR) ) has shared an announcement.
Sastasundar Healthbuddy Limited, a material subsidiary of Health X Platform Limited, has entered into a share purchase agreement with Mitsubishi Corporation and Envision India Fund for a secondary share transaction. The deal involves the sale of 10,13,766 equity shares, representing 4.68% of Sastasundar Healthbuddy’s paid-up capital, at Rs. 493.21 per share, valuing the transaction at nearly Rs. 50 crore.
Under the agreement, Envision India Fund will acquire Mitsubishi Corporation’s entire stake in Sastasundar Healthbuddy, following the satisfaction of agreed terms and conditions. Once completed, Mitsubishi Corporation will fully exit as a shareholder, potentially reshaping the subsidiary’s ownership structure and bringing in a new financial investor without diluting existing share capital at the company level.
More about Sastasundar Ventures Limited
Health X Platform Limited, formerly known as Sastasundar Ventures Limited, operates in the healthcare and digital health services space through its material subsidiary Sastasundar Healthbuddy Limited. The group focuses on technology-enabled healthcare and wellness solutions, positioning itself as a platform-based player in India’s evolving health services and pharmacy ecosystem.
Average Trading Volume: 460
Technical Sentiment Signal: Sell
Current Market Cap: 8.89B INR
See more insights into SASTASUNDR stock on TipRanks’ Stock Analysis page.